These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 8795715

  • 1. Degradation of serum amyloid A in amyloid-susceptible and amyloid-resistant mouse strains.
    Elliott-Bryant R, Liang JS, Sipe JD, Cathcart ES.
    Scand J Immunol; 1996 Sep; 44(3):223-8. PubMed ID: 8795715
    [Abstract] [Full Text] [Related]

  • 2. A unique amyloidogenic apolipoprotein serum amyloid A (apoSAA) isoform expressed by the amyloid resistant CE/J mouse strain exhibits higher affinity for macrophages than apoSAA1 and apoSAA2 expressed by amyloid susceptible CBA/J mice.
    Liang J, Elliott-Bryant R, Hajri T, Sipe JD, Cathcart ES.
    Biochim Biophys Acta; 1998 Oct 02; 1394(1):121-6. PubMed ID: 9767146
    [Abstract] [Full Text] [Related]

  • 3. Linkage of protection against amyloid fibril formation in the mouse to a single, autosomal dominant gene.
    Gonnerman WA, Elliott-Bryant R, Carreras I, Sipe JD, Cathcart ES.
    J Exp Med; 1995 Jun 01; 181(6):2249-52. PubMed ID: 7760010
    [Abstract] [Full Text] [Related]

  • 4. Catabolism of lipid-free recombinant apolipoprotein serum amyloid A by mouse macrophages in vitro results in removal of the amyloid fibril-forming amino terminus.
    Elliott-Bryant R, Liang JS, Sipe JD, Cathcart ES.
    Scand J Immunol; 1998 Sep 01; 48(3):241-7. PubMed ID: 9743207
    [Abstract] [Full Text] [Related]

  • 5. In vitro amyloid fibril formation by synthetic peptides corresponding to the amino terminus of apoSAA isoforms from amyloid-susceptible and amyloid-resistant mice.
    Kirschner DA, Elliott-Bryant R, Szumowski KE, Gonnerman WA, Kindy MS, Sipe JD, Cathcart ES.
    J Struct Biol; 1998 Dec 01; 124(1):88-98. PubMed ID: 9931277
    [Abstract] [Full Text] [Related]

  • 6. The heparin/heparan sulfate-binding site on apo-serum amyloid A. Implications for the therapeutic intervention of amyloidosis.
    Ancsin JB, Kisilevsky R.
    J Biol Chem; 1999 Mar 12; 274(11):7172-81. PubMed ID: 10066777
    [Abstract] [Full Text] [Related]

  • 7. Expression of SAA and amyloidogenesis in congenic mice of CE/J and C57BL/6 strains.
    Wang L, Liepnieks JJ, Benson MD, Kluve-Beckerman B.
    Amyloid; 2000 Mar 12; 7(1):26-31. PubMed ID: 10842702
    [Abstract] [Full Text] [Related]

  • 8. Characterization of splenic glycosaminoglycans accumulated in vivo in experimentally induced amyloid-susceptible and amyloid-resistant mice.
    Sugumaran G, Elliott-Bryant R, Phung N, Vitseva O, Kuberan B, Lech M.
    Scand J Immunol; 2004 Dec 12; 60(6):574-83. PubMed ID: 15584968
    [Abstract] [Full Text] [Related]

  • 9. SAA, an apoprotein of HDL: its structure and function.
    Benditt EP, Hoffman JS, Eriksen N, Parmelee DC, Walsh KA.
    Ann N Y Acad Sci; 1982 Dec 12; 389():183-9. PubMed ID: 7046575
    [Abstract] [Full Text] [Related]

  • 10. Direct evidence for circulating apoSAA as the precursor of tissue AA amyloid deposits.
    Tape C, Tan R, Nesheim M, Kisilevsky R.
    Scand J Immunol; 1988 Sep 12; 28(3):317-24. PubMed ID: 3194701
    [Abstract] [Full Text] [Related]

  • 11. Polymorphism of acute-phase serum amyloid A isoforms and amyloid resistance in wild-type Mus musculus czech.
    Cathcart ES, Carreras I, Elliott-Bryant R, Liang JS, Gonnerman WA, Sipe JD.
    Clin Immunol Immunopathol; 1996 Oct 12; 81(1):22-6. PubMed ID: 8808637
    [Abstract] [Full Text] [Related]

  • 12. Metabolism of the serum amyloid A proteins (SSA) in high-density lipoproteins and chylomicrons of nonhuman primates (vervet monkey).
    Parks JS, Rudel LL.
    Am J Pathol; 1983 Sep 12; 112(3):243-9. PubMed ID: 6412556
    [Abstract] [Full Text] [Related]

  • 13. Amyloid-enhancing factor: production and response in amyloidosis-susceptible and -resistant mouse strains.
    Gervais F, Hébert L, Skamene E.
    J Leukoc Biol; 1988 Apr 12; 43(4):311-6. PubMed ID: 3162509
    [Abstract] [Full Text] [Related]

  • 14. The acute phase response in apolipoprotein A-1 knockout mice: apolipoprotein serum amyloid A and lipid distribution in plasma high density lipoproteins.
    Hajri T, Elliott-Bryant R, Sipe JD, Liang JS, Hayes KC, Cathcart ES.
    Biochim Biophys Acta; 1998 Nov 02; 1394(2-3):209-18. PubMed ID: 9795222
    [Abstract] [Full Text] [Related]

  • 15. Generation of amyloid A protein by the cell lines from amyloid-susceptible and -resistant mice.
    Ham D, Skoryna SC.
    Scand J Immunol; 2004 Feb 02; 59(2):117-22. PubMed ID: 14871287
    [Abstract] [Full Text] [Related]

  • 16. Characterization of high affinity binding between laminin and the acute-phase protein, serum amyloid A.
    Ancsin JB, Kisilevsky R.
    J Biol Chem; 1997 Jan 03; 272(1):406-13. PubMed ID: 8995276
    [Abstract] [Full Text] [Related]

  • 17. Characterization of the inbred CE/J mouse strain as amyloid resistant.
    Sipe JD, Carreras I, Gonnerman WA, Cathcart ES, de Beer MC, de Beer FC.
    Am J Pathol; 1993 Nov 03; 143(5):1480-5. PubMed ID: 7901995
    [Abstract] [Full Text] [Related]

  • 18. Murine tissue amyloid protein AA. NH2-terminal sequence identity with only one of two serum amyloid protein (ApoSAA) gene products.
    Hoffman JS, Ericsson LH, Eriksen N, Walsh KA, Benditt EP.
    J Exp Med; 1984 Feb 01; 159(2):641-6. PubMed ID: 6693836
    [Abstract] [Full Text] [Related]

  • 19. Plasma clearance kinetics of the amyloid-related high density lipoprotein apoprotein, serum amyloid protein (apoSAA), in the mouse. Evidence for rapid apoSAA clearance.
    Hoffman JS, Benditt EP.
    J Clin Invest; 1983 Apr 01; 71(4):926-34. PubMed ID: 6833494
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the binding and endocytosis of high-density lipoprotein from healthy (HDL) and inflamed (HDL(SAA)) donors by murine macrophages of four different mouse strains.
    Röcken C, Kisilevsky R.
    Virchows Arch; 1998 Jun 01; 432(6):547-55. PubMed ID: 9672197
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.